Advertisement

Specialty News

August 03, 2016
August 03, 2016
*
MORE
July 28, 2016
July 28, 2016
FDA has lowered some of the fees for new drug applications (NDAs) and biologic license applications (BLAs) by more than $300,000. For 2017, the fee...
FDA has lowered some of the fees for new drug applications (NDAs) and biologic license applications (BLAs) by more than $300,000. For 2017, the fee for an NDA requiring clinical data or a biosimilar application requiring clinical data will be $2,038,100, which is $336,100 less than the $2.37 million fee from 2016.
MORE
July 28, 2016
July 28, 2016
A newly released report by the Washington State Department of Health indicates that more than 90,000 people in the state are likely infected with...
A newly released report by the Washington State Department of Health indicates that more than 90,000 people in the state are likely infected with hepatitis C virus (HCV). The report describes the scale of the problem and provides recommendations for future action in the areas of prevention, testing, and treatment for HCV infections.
MORE
August 04, 2016
July 28, 2016
FDA has approved dasabuvir–ombitasvir–paritaprevir–ritonavir (Viekira XR—AbbVie) for chronic hepatitis C virus (HCV) genotype 1 infection. The new...
FDA has approved dasabuvir–ombitasvir–paritaprevir–ritonavir (Viekira XR—AbbVie) for chronic hepatitis C virus (HCV) genotype 1 infection. The new drug contains the same ingredients as Viekira Pak; however, it offers patients a simpler drug regimen.
MORE
July 21, 2016
July 21, 2016
Kroger announced Wednesday that one of its subsidiaries is acquiring Modern HC Holdings Inc., the corporate parent of ModernHealth. Financial terms...
Kroger announced Wednesday that one of its subsidiaries is acquiring Modern HC Holdings Inc., the corporate parent of ModernHealth. Financial terms of the agreement were not revealed, but Kroger said Modern HC Holdings would become part of its Axium Pharmacy operations.
MORE
July 21, 2016
July 21, 2016
Since its launch in July 2014, Genoa, a QoL Healthcare Co., has increased its pharmacy count from 214 to 309 and nearly doubled annual sales to $1.1...
Since its launch in July 2014, Genoa, a QoL Healthcare Co., has increased its pharmacy count from 214 to 309 and nearly doubled annual sales to $1.1 billion.
MORE
July 14, 2016
July 14, 2016
NIH has awarded approximately $30 million in annual funding over the next 5 years to six research collaborations working to advance basic medical...
NIH has awarded approximately $30 million in annual funding over the next 5 years to six research collaborations working to advance basic medical science toward an HIV cure. The awards are a part of President Barack Obama's pledge to invest in HIV cure research.
MORE
July 14, 2016
July 14, 2016
With assistance from a high tech robot, NIH researchers have identified and tested a molecule that shows promise as a possible treatment for the...
With assistance from a high tech robot, NIH researchers have identified and tested a molecule that shows promise as a possible treatment for the rare Gaucher disease and the more common Parkinson’s disease.
MORE
July 14, 2016
July 14, 2016
Antiretroviral therapy has allowed more patients with HIV to live into their 60s and even 70s, but HIV medications are typically toxic for the...
Antiretroviral therapy has allowed more patients with HIV to live into their 60s and even 70s, but HIV medications are typically toxic for the people who take them.
MORE
July 01, 2016
July 12, 2016
Tumor lysis syndrome (TLS), a potential complication of cancer treatment, occurs when malignant cells quickly lyse, or break open, and the internal...
Tumor lysis syndrome (TLS), a potential complication of cancer treatment, occurs when malignant cells quickly lyse, or break open, and the internal contents of the cell spill out into the bloodstream, causing metabolic abnormalities. Most often occurring 48–72 hours after the initiation of cancer treatment for hematologic malignancies, TLS may present before cancer therapy and occur with other tumor types, such as breast cancer, small cell lung cancer, and neuroblastoma.1-3
MORE

Pages